GOPIVEO
LIVE

Serial Number

97150926

Owner

Antibe Therapeutics Inc.

Attorney

Frances M. Jagla

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

GOPIVEO Trademark

Serial Number: 97150926 • Registration: 8017102

GOPIVEO is a trademark filed by Antibe Therapeutics Inc. on December 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Antibe Therapeutics Inc. (2 trademarks)

15 Prince Arthur Avenue
Toronto, Ontario M5R1B2 , CA

Entity Type: 03

Trademark Details

Filing Date

December 1, 2021

Registration Date

November 11, 2025

Published for Opposition

September 23, 2025

Goods & Services

Pharmaceuticals, namely, anti-inflammatories; anti-inflammatory pharmaceutical preparations; preparations for the relief of pain; pharmaceutical preparations for the relief of pain

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2025 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Oct 30, 2025 CHPB
ASSIGNED TO PETITION STAFF
Oct 29, 2025 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 23, 2025 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 18, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 17, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 17, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 17, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 30, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 30, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 30, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 28, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 28, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 28, 2025 CNSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 15, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 18, 2024 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 8, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 8, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 8, 2023 GNSL
SUSPENSION LETTER WRITTEN
Sep 8, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2023 CRFA
ASSIGNED TO LIE
Sep 7, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 24, 2023 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 6, 2023 RCCK
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 5, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 5, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 5, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 15, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 15, 2022 GNSL
SUSPENSION LETTER WRITTEN
Sep 15, 2022 CNSL
ASSIGNED TO EXAMINER
Sep 10, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2021 NWAP